D.E. Shaw & Co
CYRX icon

D.E. Shaw & Co’s CryoPort CYRX Stock Holding History

D.E. Shaw & Co’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Sell
158,225
-91,078
-37% -$823K ﹤0.01% 3239
2025
Q4 		$2.39M Sell
249,303
-137,492
-36% -$1.3M ﹤0.01% 2915
2025
Q3 		$3.67M Buy
386,795
+4,116
+1% +$34.6K ﹤0.01% 2484
2025
Q2 		$2.85M Buy
382,679
+52,242
+16% +$324K ﹤0.01% 2472
2025
Q1 		$2.01M Sell
330,437
-77,948
-19% -$539K ﹤0.01% 2594
2024
Q4 		$3.18M Buy
408,385
+68,474
+20% +$510K ﹤0.01% 2353
2024
Q3 		$2.76M Buy
339,911
+226,964
+201% +$1.86M ﹤0.01% 2443
2024
Q2 		$780K Sell
112,947
-24,484
-18% -$330K ﹤0.01% 3343
2024
Q1 		$2.43M Sell
137,431
-52,134
-28% -$825K ﹤0.01% 2476
2023
Q4 		$2.94M Buy
+189,565
New +$2.48M ﹤0.01% 2353
2023
Q3 		– Sell
-41,110
Closed -$709K – 4296
2023
Q2 		$709K Sell
41,110
-49,354
-55% -$1.01M ﹤0.01% 3259
2023
Q1 		$2.17M Buy
90,464
+11,841
+15% +$257K ﹤0.01% 2631
2022
Q4 		$1.36M Buy
+78,623
New +$1.66M ﹤0.01% 3226
2021
Q3 		– Sell
-6,698
Closed -$413K – 5014
2021
Q2 		$423K Sell
6,698
-49,563
-88% -$2.79M ﹤0.01% 4111
2021
Q1 		$2.93M Sell
56,261
-270,710
-83% -$16.5M ﹤0.01% 2254
2020
Q4 		$14.3M Sell
326,971
-84,376
-21% -$4.02M 0.01% 1151
2020
Q3 		$19.5M Buy
411,347
+380,096
+1,216% +$15.4M 0.02% 849
2020
Q2 		$945K Sell
31,251
-83,230
-73% -$1.85M ﹤0.01% 2983
2020
Q1 		$1.95M Sell
114,481
-18,183
-14% -$318K ﹤0.01% 2190
2019
Q4 		$2.18M Sell
132,664
-118,671
-47% -$1.77M ﹤0.01% 2393
2019
Q3 		$4.11M Buy
251,335
+202,906
+419% +$4.07M 0.01% 1799
2019
Q2 		$887K Buy
48,429
+783
+2% +$12.4K ﹤0.01% 2748
2019
Q1 		$616K Buy
+47,646
New +$518K ﹤0.01% 2889
2018
Q4 		– Sell
-21,764
Closed -$279K – 3796
2018
Q3 		$279K Buy
+21,764
New +$311K ﹤0.01% 3390

Other funds holding CYRX

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return

D.E. Shaw & Co's CYRX Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CryoPort (CYRX) stake by 37% in Q1 2026, selling an estimated $823K and leaving 158,225 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #3239.

D.E. Shaw & Co first reported a position in CYRX in Q3 2018 and has held it in 24 quarters since. The position peaked at $19.5M in Q3 2020. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

  • D.E. Shaw & Co held 158,225 shares of CryoPort worth $1.31M as of Q1 2026.
  • D.E. Shaw & Co sold 91,078 CryoPort shares in Q1 2026, an estimated $823K.
  • CryoPort made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3239 holding.
  • D.E. Shaw & Co first reported a position in CryoPort in Q3 2018 and has held it in 24 quarters since.
  • D.E. Shaw & Co's CryoPort position peaked at $19.5M in Q3 2020.
  • 165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.